Recruiting NCT06892093
No phase Interventional China
HER2-positive Breast Cancer · Diarrhea Caused by Drug · Neratinib
Not yet recruiting NCT07653698
No phase Interventional —
Breast Cancer · Cancer Cachexia
Recruiting NCT07597629
Phase II Interventional China
Advanced Breast Cancer
Recruiting NCT04332588
Phase I Interventional United States
HER2-positive Breast Cancer
Enrolling by invitation NCT07651345
No phase Interventional Singapore
Mammogram Uptake · Breast Cancer · Breast Neoplasm
Not yet recruiting NCT07331077
No phase Interventional United States
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8
Not yet recruiting NCT07649902
No phase Interventional —
Breast Cancer · Radiodermatitis
Recruiting NCT03096418
Phase IV Interventional United States
Breast Neoplasm Female
Not yet recruiting NCT07651696
No phase Interventional —
Breast Cancer Female
Recruiting NCT05557877
Phase II Interventional United States
Breast Carcinoma
Recruiting NCT07650305
No phase Interventional Egypt
Breast Cancer
Recruiting NCT06028022
Phase II Interventional United States
Estrogen Receptor-Positive Breast Carcinoma
Recruiting NCT04517838
— Observational United States
Breast Adenocarcinoma · HER2-Positive Breast Carcinoma · Anatomic Stage I Breast Cancer AJCC v8
Recruiting NCT07278726
— Observational Italy, Switzerland
ALND · Sentinel Lymph Node Biopsy (SLNB) · Targeted Axillary Dissection (TAD)
Recruiting NCT07200427
No phase Interventional Greece, Lithuania +2
Breast Cancer Prevention
Recruiting NCT04997993
Phase I Interventional United States
PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer
Recruiting NCT05704283
Early Phase I Interventional United States
Breast Carcinoma
Not yet recruiting NCT07648810
No phase Interventional —
Breast Cancer - Female
Recruiting NCT05916079
— Observational France
Breastfeeding · Smartphone
Recruiting NCT07647016
Phase II Interventional China
Breast Cancer
Recruiting NCT07513311
No phase Interventional United States
Triple Negative Breast Cancer (TNBC)
Recruiting NCT06960707
Phase III Interventional United States
Breast Cancer
Not yet recruiting NCT07300475
Phase I Interventional United States
Triple Negative Breast Cancer
Not yet recruiting NCT07647029
Phase II Interventional —
Breast Cancer Patients at High Risk of Chemotherapy-induced Thrombocytopenia (CTIT)
Recruiting NCT07647263
Phase II Interventional China
HER2-positive Breast Cancer
Not yet recruiting NCT07612267
Phase IV Interventional United States, Canada +6
Lactation · Inflammatory Bowel Disease
Recruiting NCT07557654
— Observational China
Breast Cancer
Recruiting NCT06930521
No phase Interventional Canada
Cardiovascular Health · Breast Cancer · Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Recruiting NCT07474090
No phase Interventional United States
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
Enrolling by invitation NCT07644845
— Observational United States
Breast Cancer
Recruiting NCT05178498
— Observational United States
Breast Atypical Ductal Hyperplasia · Breast Atypical Lobular Hyperplasia · Breast Carcinoma
Recruiting NCT07646171
— Observational Israel
Hormone Receptor Positive Breast Cancer
Not yet recruiting NCT07644455
No phase Interventional Brazil
Breast Cancer
Recruiting NCT07644702
No phase Interventional United States
Breast Carcinoma
Recruiting NCT03572374
No phase Interventional United States
Breast Cancer
Recruiting NCT05982496
Phase II Interventional Italy
Breast Cancer Female · Lobular Breast Carcinoma · PET/MRI
Recruiting NCT07602374
No phase Interventional United States
Breast Surgery
Recruiting NCT07441889
Phase I / Phase II Interventional United States
Breast Cancer · Prostate Cancer
Recruiting NCT07273812
No phase Interventional Iraq
Breast Cancer · Breast Neoplasm · Chemotherapy-Related Toxicities
Recruiting NCT06763328
Phase III Interventional United States
Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8
Recruiting NCT07454499
No phase Interventional United States
Cancer
Recruiting NCT05950945
Phase III Interventional United States, Australia +8
Breast Cancer
Recruiting NCT07211178
— Observational United States
Breast Cancer · TNBC - Triple-Negative Breast Cancer · HR Positive/HER-2 Negative Breast Cancer
Not yet recruiting NCT07645235
Phase I Interventional —
Urinary Tract Infections
Recruiting NCT07222215
Phase II Interventional United States
Estrogen-receptor-positive Breast Cancer · Metastatic Breast Cancer · Breast Cancer
Recruiting NCT07358377
Phase I Interventional Australia
Breast Cancer
Recruiting NCT06974929
Phase I / Phase II Interventional China
Breast Cancer
Recruiting NCT06309290
No phase Interventional Chile
Prehabilitation · Breast Cancer · Postmenopause
Not yet recruiting NCT07560475
Phase II Interventional China
HER2positive · Advanced Breast Cancer · HER2 + Breast Cancer
Not yet recruiting NCT07633808
No phase Interventional Palestinian Territories
Diaper Dermatitis
Recruiting NCT06224673
Phase II Interventional United States
HER2 Low Breast Carcinoma · Triple Negative Breast Cancer · Hormone-receptor-positive Breast Cancer
Recruiting NCT07339306
No phase Interventional China
Mammary Tumor · Nipple Discharge · Breast Ductal Carcinoma In Situ
Not yet recruiting NCT07643428
Phase II Interventional United States
Breast Cancer
Recruiting NCT07631052
Phase II Interventional Canada
ER-positive, HER2-negative Breast Cancer · Breast Cancer Stage I · Breast Cancer Stage II
Recruiting NCT03936478
Phase II Interventional United States
Breast Cancer · DCIS · LCIS
Recruiting NCT06994416
— Observational China
Mammary Tumor · Nipple Discharge
Recruiting NCT05736354
— Observational United States
Breast Implant; Complications · Infection or Inflammation
Not yet recruiting NCT07641985
No phase Interventional Netherlands
Breast Cancer · Breast Reconstruction · Breast Reconstruction After Mastectomy
Not yet recruiting NCT07102940
Phase II Interventional —
Breast Cancer · HER 2 Negative Breast Cancer · HR Positive/HER-2 Negative Breast Cancer
Recruiting NCT05902507
— Observational United States
Breast Cancer
Recruiting NCT07253987
No phase Interventional Czechia
Prostate Cancer Patients · Breast Cancer Patients
Not yet recruiting NCT07618923
Phase II Interventional —
Breast Cancer · HR Positive/HER2 Low Breast Cancer
Not yet recruiting NCT07643584
Phase II Interventional —
Breast Cancer
Recruiting NCT07608848
Early Phase I Interventional Australia
Metastatic Breast Cancer · Metastatic Prostate Cancer · GRPR-Targeted Molecular Imaging
Recruiting NCT07198724
Phase I / Phase II Interventional United States
Metastatic Breast Cancer · HER2 Low Breast Carcinoma · HER2-negative Breast Cancer
Recruiting NCT06771609
Phase II Interventional China
Advanced Triple-negative Breast Cancer
Recruiting NCT07273357
— Observational Sweden
Geriatric Assessment · Adjuvant Drug Therapy · Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Recruiting NCT06839560
Phase II Interventional China
Brain Metastasis From Advanced HER2-negative Breast Cancer
Not yet recruiting NCT07638150
No phase Interventional United States
Breast Cancer
Recruiting NCT06981208
No phase Interventional United States
Breast Cancer · Cancer of the Breast
Recruiting NCT06926868
Phase II / Phase III Interventional United States, Argentina +26
Breast Neoplasms
Recruiting NCT06839547
— Observational China
Advanced Breast Cancer Brain Metastasis
Recruiting NCT07638774
No phase Interventional China
Locally Advanced or Metastatic Breast Cancer
Recruiting NCT06908668
Phase II Interventional China
HER2-Negative Locally Advanced Breast Cancer
Recruiting NCT06107933
— Observational United States
Infant Development · Breast Feeding · Environmental Exposure
Recruiting NCT07635342
Phase II Interventional China
HER2-positive Breast Cancer
Recruiting NCT05704829
Phase II Interventional Germany
HER2-positive Early Breast Cancer
Recruiting NCT06085313
No phase Interventional United States
Cancer of Breast · Depressive Symptoms · Cancer Pain
Not yet recruiting NCT07635654
No phase Interventional —
Invasive Lobular Breast Carcinoma
Not yet recruiting NCT07006662
— Observational United Kingdom
Breast Cancer Female
Not yet recruiting NCT07598084
— Observational —
Breast Neoplasms · Artificial Intelligence (AI) · Magnetic Resonance Imaging (MRI)
Recruiting NCT06776861
— Observational China
Advanced Breast Cancer
Recruiting NCT07218250
No phase Interventional United States
Breast Cancer
Not yet recruiting NCT07631468
— Observational United States
Breast Surgery
Recruiting NCT07630402
No phase Interventional United States
Breast Cancer With Low to Intermediate HER2 Expression
Recruiting NCT06297265
No phase Interventional United States
Anatomic Stage 0 Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8 · Localized Breast Carcinoma
Not yet recruiting NCT07630103
Phase II Interventional China
Advanced Breast Cancer
Not yet recruiting NCT07628517
— Observational —
Mammaplasty · Breast Reconstruction
Recruiting NCT07007559
Phase II Interventional United States, Canada +6
Breast Cancer, Metastatic
Not yet recruiting NCT07630948
Phase IV Interventional Slovenia
Breast Cancer · Adherence, Medication
Recruiting NCT04529044
Phase II Interventional United States
Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Breast Carcinoma · Recurrent Breast Carcinoma
Recruiting NCT05035836
Phase II Interventional United States
Breast Cancer · HER2-positive
Recruiting NCT06240195
— Observational Italy
Breast Cancer
Recruiting NCT03417115
— Observational Germany
Breast Cancer
Not yet recruiting NCT07628504
Phase III Interventional China
Adjuvant Drug Therapy
Recruiting NCT07483307
Phase II Interventional United States
Breast Cancer · HER2-negative Breast Cancer · HER2 Negative Breast Carcinoma
Not yet recruiting NCT07627269
No phase Interventional Netherlands
Breast Cancer
Recruiting NCT02541435
— Observational Norway
Breast Neoplasms · Cardiovascular Diseases
Recruiting NCT04638725
— Observational France
HER2-positive Breast Cancer
Recruiting NCT07518173
Phase III Interventional China
HER2-positive Breast Cancer